Medical News |
- Psychosis prevalent in bipolar II depression
- Parental mental disorder linked to wide range of such disorders in offspring
- PLATO genetic substudy: Ticagrelor may eliminate need for ACS genetic testing
- Risk-reducing surgery effective in <i>BRCA1/2</i> mutation carriers
- Physicians not confident in knowledge about prostate cancer screening
- Atherogenic dyslipidemia commonly found with stable coronary disease
- ALPHA OMEGA: Few post-MI patients benefit from low-dose n-3 fatty acids
- Breastfeeding may lower diabetes risk in mothers
- ACE I-ARB combination therapy not detrimental to severely hypertensive diabetics
- CURE ACTIVE: Loss-of-function <i>CYP2C19</i> alleles do not affect clopidogrel efficacy
- PLATO genetic substudy: Ticagrelor may eliminate need for ACS genetic testing
| Psychosis prevalent in bipolar II depression Posted: 01 Sep 2010 05:00 PM PDT Around a fifth of patients with bipolar II disorder have a history of psychosis during depression, say researchers who suggest that bipolar II disorder with psychosis may represent a distinct phenotype. |
| Parental mental disorder linked to wide range of such disorders in offspring Posted: 01 Sep 2010 05:00 PM PDT A parental history of serious mental disorder is associated with an increased risk for a wide range of mental health disorders in children, including disorders that were previously thought to be unrelated, researchers have found. |
| PLATO genetic substudy: Ticagrelor may eliminate need for ACS genetic testing Posted: 31 Aug 2010 05:00 PM PDT Results of a genetic substudy of the PLATO trial show that ticagrelor treatment for acute coronary syndromes results in fewer CV death, myocardial infarction, or stroke events in comparison with clopidogrel, irrespective of patient genotype. |
| Risk-reducing surgery effective in <i>BRCA1/2</i> mutation carriers Posted: 31 Aug 2010 05:00 PM PDT Women at increased risk for breast and ovarian cancer because of inherited mutations in the BRCA1 or BRCA2 genes gain significant health benefits from prophylactic mastectomy or salpingo-oophorectomy, study findings indicate. |
| Physicians not confident in knowledge about prostate cancer screening Posted: 31 Aug 2010 05:00 PM PDT US primary care physicians are able to correctly identify prostate cancer risk factors but are not confident in their knowledge about prostate cancer screening and overall prostate cancer risk, show study results. |
| Atherogenic dyslipidemia commonly found with stable coronary disease Posted: 31 Aug 2010 05:00 PM PDT A significant proportion of patients with coronary artery disease could benefit from efforts to increase their high-density lipoprotein cholesterol levels and reduce triglycerides, researchers say. |
| ALPHA OMEGA: Few post-MI patients benefit from low-dose n-3 fatty acids Posted: 31 Aug 2010 05:00 PM PDT The overall rate of cardiovascular events in post-myocardial infarction patients is not reduced by low doses of dietary n-3 fatty acids, although some subgroups may benefit, the ALPHA OMEGA study results show. |
| Breastfeeding may lower diabetes risk in mothers Posted: 31 Aug 2010 05:00 PM PDT Mothers who breastfeed their children for at least 1 month may have a lower risk for diabetes than those who breastfeed for less time or do not breast feed at all, US researchers report. |
| ACE I-ARB combination therapy not detrimental to severely hypertensive diabetics Posted: 31 Aug 2010 05:00 PM PDT Australian researchers suggest that combined ACE inhibitor and angiotensin receptor blocker antihypertensive therapy does not produce more renal damage than monotherapy with either drug in diabetes patients with severe hypertension. |
| CURE ACTIVE: Loss-of-function <i>CYP2C19</i> alleles do not affect clopidogrel efficacy Posted: 31 Aug 2010 05:00 PM PDT CYP2C19 loss-of-function carrier status does not influence the effect of clopidogrel compared with placebo in patients with acute coronary syndromes or atrial fibrillation, according to results from the CURE ACTIVE study. |
| PLATO genetic substudy: Ticagrelor may eliminate need for ACS genetic testing Posted: 31 Aug 2010 05:00 PM PDT Results of a genetic substudy of the PLATO trial show that ticagrelor treatment for acute coronary syndromes results in fewer CV death, myocardial infarction, or stroke events in comparison with clopidogrel, irrespective of patient genotype. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment